Gerald Timelthaler

4.5k total citations
40 papers, 942 citations indexed

About

Gerald Timelthaler is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Gerald Timelthaler has authored 40 papers receiving a total of 942 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 14 papers in Oncology and 8 papers in Immunology. Recurrent topics in Gerald Timelthaler's work include Fibroblast Growth Factor Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Gerald Timelthaler is often cited by papers focused on Fibroblast Growth Factor Research (5 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Gerald Timelthaler collaborates with scholars based in Austria, Hungary and Germany. Gerald Timelthaler's co-authors include Michael Trauner, Joanna I. Loizou, Robert Eferl, Thomas Reiberger, Josef Jiricny, Joana Ferreira da Silva, Amandine Moretton, Nataliya Rohr‐Udilova, Walter Berger and Merima Herac and has published in prestigious journals such as Angewandte Chemie International Edition, Nature Communications and PLoS ONE.

In The Last Decade

Gerald Timelthaler

37 papers receiving 937 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerald Timelthaler Austria 17 488 272 186 140 137 40 942
Chunjing Wu United States 19 540 1.1× 315 1.2× 150 0.8× 143 1.0× 278 2.0× 38 1.0k
Guang Wu China 20 540 1.1× 239 0.9× 192 1.0× 90 0.6× 273 2.0× 48 927
Huiwei Sun China 16 388 0.8× 249 0.9× 74 0.4× 80 0.6× 280 2.0× 24 783
Faqing Tang China 21 910 1.9× 311 1.1× 119 0.6× 120 0.9× 338 2.5× 55 1.4k
Ying‐Hui Zhu China 20 821 1.7× 281 1.0× 200 1.1× 173 1.2× 464 3.4× 49 1.3k
Kejun Nan China 16 350 0.7× 323 1.2× 137 0.7× 135 1.0× 186 1.4× 42 791
Yulin Sun China 20 649 1.3× 231 0.8× 84 0.5× 163 1.2× 375 2.7× 56 1.0k
Jehng-Kang Wang Taiwan 18 295 0.6× 134 0.5× 157 0.8× 60 0.4× 208 1.5× 40 854
Franca Maria Tuccillo Italy 14 547 1.1× 172 0.6× 214 1.2× 61 0.4× 176 1.3× 36 963

Countries citing papers authored by Gerald Timelthaler

Since Specialization
Citations

This map shows the geographic impact of Gerald Timelthaler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald Timelthaler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald Timelthaler more than expected).

Fields of papers citing papers by Gerald Timelthaler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald Timelthaler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald Timelthaler. The network helps show where Gerald Timelthaler may publish in the future.

Co-authorship network of co-authors of Gerald Timelthaler

This figure shows the co-authorship network connecting the top 25 collaborators of Gerald Timelthaler. A scholar is included among the top collaborators of Gerald Timelthaler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerald Timelthaler. Gerald Timelthaler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schelch, Karin, Dominik Kirchhofer, Gerald Timelthaler, et al.. (2025). Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma. British Journal of Cancer. 133(9). 1391–1400.
2.
Spittler, Andreas, Franziska Ferk, Miroslav Mišík, et al.. (2025). Small Particles, Big Problems: Polystyrene nanoparticles induce DNA damage, oxidative stress, migration, and mitogenic pathways predominantly in non-malignant lung cells. Journal of Hazardous Materials. 495. 139129–139129. 3 indexed citations
3.
Boettiger, Kristiina, Zsolt Megyesfalvi, Dominik Kirchhofer, et al.. (2025). Unveiling the powerhouse: ASCL1-driven small cell lung cancer is characterized by higher numbers of mitochondria and enhanced oxidative phosphorylation. Cancer & Metabolism. 13(1). 16–16.
4.
Mosca, Elena, Christine Pirker, Markus Schosserer, et al.. (2024). The tyrosine kinase inhibitor Nintedanib induces lysosomal dysfunctionality: Role of protonation-dependent crystallization processes. Chemico-Biological Interactions. 403. 111243–111243. 1 indexed citations
5.
Lang, Christian, Zsolt Megyesfalvi, Felicitas Oberndorfer, et al.. (2024). C-Myc protein expression indicates unfavorable clinical outcome in surgically resected small cell lung cancer. World Journal of Surgical Oncology. 22(1). 57–57. 2 indexed citations
6.
Moser, Doris, Katy Schmidt, Petra Pjevac, et al.. (2023). Defects in microvillus crosslinking sensitize to colitis and inflammatory bowel disease. EMBO Reports. 24(10). e57084–e57084. 11 indexed citations
7.
Mohr, Thomas, Martin Holcmann, Gerald Timelthaler, et al.. (2023). FAM3C / ILEI protein is elevated in psoriatic lesions and triggers psoriasiform hyperproliferation in mice. EMBO Molecular Medicine. 15(7). e16758–e16758. 6 indexed citations
8.
Schrempf, Anna, Dominik Kirchhofer, Gerald Timelthaler, et al.. (2022). POLθ processes ssDNA gaps and promotes replication fork progression in BRCA1-deficient cells. Cell Reports. 41(9). 111716–111716. 47 indexed citations
9.
Rohr‐Udilova, Nataliya, Kaoru Tsuchiya, Gerald Timelthaler, et al.. (2021). Morphometric Analysis of Mast Cells in Tumor Predicts Recurrence of Hepatocellular Carcinoma After Liver Transplantation. Hepatology Communications. 5(11). 1939–1952. 9 indexed citations
10.
Dinhof, Carina, Christine Pirker, Dominik Kirchhofer, et al.. (2020). p53 Loss Mediates Hypersensitivity to ETS Transcription Factor Inhibition Based on PARylation-Mediated Cell Death Induction. Cancers. 12(11). 3205–3205. 12 indexed citations
11.
Brusilovskaya, Ksenia, Philipp Königshofer, David Bauer, et al.. (2020). Soluble guanylyl cyclase stimulation and phosphodiesterase‐5 inhibition improve portal hypertension and reduce liver fibrosis in bile duct–ligated rats. United European Gastroenterology Journal. 8(10). 1174–1185. 26 indexed citations
12.
Pirker, Christine, Carina Dinhof, Bernhard Englinger, et al.. (2019). Subcellular Duplex DNA and G‐Quadruplex Interaction Profiling of a Hexagonal PtII Metallacycle. Angewandte Chemie International Edition. 58(24). 8007–8012. 44 indexed citations
13.
Pirker, Christine, Carina Dinhof, Bernhard Englinger, et al.. (2019). Subcellular Duplex DNA and G‐Quadruplex Interaction Profiling of a Hexagonal PtII Metallacycle. Angewandte Chemie. 131(24). 8091–8096. 9 indexed citations
14.
Jomrich, Gerd, et al.. (2019). Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas. Cells. 8(9). 1092–1092. 14 indexed citations
15.
Ahmed, Mohamed A., Gerald Timelthaler, Gerd Jomrich, et al.. (2018). FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer. Journal of Cancer Research and Clinical Oncology. 145(1). 77–86. 13 indexed citations
16.
Timelthaler, Gerald, Markus Grubinger, Cédric Coulouarn, et al.. (2018). Transforming growth factor-βeta and AXL collaborate to induce CXCL5 and neutrophil infiltration in hepatocellular carcinoma. Journal of Hepatology. 68. S674–S675. 3 indexed citations
17.
Rohr‐Udilova, Nataliya, Florian Klinglmüller, Rolf Schulte‐Hermann, et al.. (2018). Deviations of the immune cell landscape between healthy liver and hepatocellular carcinoma. Scientific Reports. 8(1). 6220–6220. 130 indexed citations
18.
Rodríguez-Carrasco, Yelko, Bernhard Englinger, Gerald Timelthaler, et al.. (2017). The Natural Fungal Metabolite Beauvericin Exerts Anticancer Activity In Vivo: A Pre-Clinical Pilot Study. Toxins. 9(9). 258–258. 28 indexed citations
19.
Bileck, Andrea, Thomas Mohr, Gerald Timelthaler, et al.. (2017). Proteomic profiling identifies markers for inflammation-related tumor–fibroblast interaction. Clinical Proteomics. 14(1). 33–33. 16 indexed citations
20.
Schütz, Birgit, Gerald Timelthaler, Robert Eferl, et al.. (2016). Generation of metastatic melanoma specific antibodies by affinity purification. Scientific Reports. 6(1). 37253–37253. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chunjing Wu Breakdown of academic impact, for papers by Guang Wu Breakdown of academic impact, for papers by Huiwei Sun Breakdown of academic impact, for papers by Faqing Tang Breakdown of academic impact, for papers by Ying‐Hui Zhu Breakdown of academic impact, for papers by Kejun Nan Breakdown of academic impact, for papers by Yulin Sun Breakdown of academic impact, for papers by Jehng-Kang Wang Breakdown of academic impact, for papers by Franca Maria Tuccillo
Rankless by CCL
2026